#Sweden #Gothenburg #revenue growth #sales report #Zinzino AB

Zinzino AB Preliminary Sales Report for January 2025

In a remarkable start to the year, Zinzino AB (PUBL.) announced a staggering 57% increase in group revenue compared to the previous year. The preliminary sales report for January 2025 reflects a significant surge, with total revenues amounting to SEK 233.4 million, up from SEK 149.0 million in January 2024. This positive trend is occlusively illustrated by a robust growth rate of 62% within Zinzino's sales markets, leading to revenues of SEK 228.7 million, compared to SEK 140.9 million the previous year.

Breakdown of Revenue Growth

The growth in revenue was not uniformly distributed across all regions. A closer inspection of sales reveals diverse performance levels:

• - Nordics: Revenue increased by 12% to SEK 25.5 million from SEK 22.8 million.
• - Central Europe: This region showed the highest growth, soaring by 70%, resulting in sales of SEK 69.5 million, compared to SEK 40.9 million last year.
• - East Europe had more modest growth, with revenues increasing by 8% to SEK 34.2 million.
• - South West Europe witnessed a phenomenal 101% increase, totaling SEK 44.6 million.
• - The Baltics experienced a 29% growth in revenues, reaching SEK 10.3 million.
• - In North America, the company reported a 113% surge, with sales climbing to SEK 22.2 million.
• - The Asia-Pacific region astonished with a remarkable 420% growth, totaling SEK 20.8 million in sales.
• - Africa also saw an impressive increase, growing by 60% to SEK 1.6 million.

On the other hand, Faun Pharma, a subsidiary of Zinzino, experienced a dip in external sales, plummeting by 42% from SEK 8.1 million to SEK 4.7 million. While this segment's decline is concerning, it did not overshadow Zinzino's overall upward trajectory in total group revenue.

Implications for Future Growth

Zinzino's strong performance can be attributed to multiple factors, including innovative product offerings and an expanding market presence. As demand for health and wellness products continues to rise, Zinzino has strategically positioned itself to capture market share across various regions. This is clearly evident in the notable revenue boosts in North America and the Asia-Pacific region, where consumer interest in health supplements is rapidly growing.

CEO Dag Bergheim Pettersen commented on the encouraging results, emphasizing the company's commitment to sustainability and wellness. He stated, “Our results underline the effectiveness of our strategy and the dedication of our teams across the globe. We remain aligned with our mission to transform the health of our customers.”

Conclusion

With the preliminary sales report painting a promising picture for January 2025, Zinzino AB is poised for continued success in the upcoming quarters. The company’s ability to adapt to market demands and leverage growth opportunities across its sales networks positions it favorably in the competitive landscape of health and wellness products. As we move further into the year, investors and stakeholders will undoubtedly keep a keen eye on Zinzino's ongoing performance and strategic initiatives.

For more insights and detailed information, please visit Zinzino's official site.